Please use this identifier to cite or link to this item:
High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus Disease 2019
Cao, W
Liu, X
Bai, T
Fan, H
Hong, K
Song, H
Han, Y
Lin, L
Ruan, L
Li, T
Acceso Abierto
Abstract The outbreak of Coronavirus Disease 2019 (COVID-19) has spread rapidly in China. Till now, no definite effective treatment has been identified. We reported on three patients of severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19.
Open Forum Infectious Diseases
Appears in Collections:Artículos científicos

Upload archives

File SizeFormat 
102791.pdf431.98 kBAdobe PDFView/Open